Canada markets close in 3 hours 2 minutes

NeuBase Therapeutics Inc (O7P.BE)

Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
0.35100.0000 (0.00%)
As of 08:27AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-09-30
2021-09-30
2020-09-30
2019-09-30
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
18,431
21,449
14,363
6,946
16,415
Selling General and Administrative
11,530
11,870
12,202
10,123
9,096
Total Operating Expenses
29,961
33,318
26,565
17,069
25,510
Operating Income or Loss
-29,961
-33,318
-26,565
-17,069
-25,510
Interest Expense
10.696
24.047
32.33
7.686
128.951
Total Other Income/Expenses Net
-739.692
-582.62
1,176
-307.528
-492.889
Income Before Tax
-30,417
-33,776
-25,409
-17,385
-26,132
Income from Continuing Operations
-30,417
-33,776
-25,409
-17,385
-26,132
Net Income
-30,417
-33,776
-25,409
-17,385
-26,132
Net Income available to common shareholders
-30,417
-33,776
-25,409
-17,385
-26,132
Basic EPS
-3.44
-20.80
-18.60
-17.80
-65.20
Diluted EPS
-3.44
-20.80
-18.60
-17.80
-65.20
Basic Average Shares
2,825
1,624
1,365
981.014
413.585
Diluted Average Shares
2,825
1,624
1,365
981.014
413.585